Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 8/20 | 0.36 |
| ▸ | F10 | P00742 | 8/20 | 0.36 |
| ▸ | F7 | P08709 | 5/20 | 0.36 |
| ▸ | PLG | P00747 | 5/20 | 0.36 |
| ▸ | F3 | P13726 | 4/20 | 0.36 |
| ▸ | PLAU | P00749 | 5/20 | 0.35 |
| ▸ | PLAT | P00750 | 5/20 | 0.35 |
| ▸ | KLK1 | P06870 | 2/20 | 0.35 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.33 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6562060 | 0.88 | PLA2G7 (0.39) | PLA2G7ADORA2AEGLN1 | |
| SCHEMBL6563277 | 0.81 | F2 (0.41) | F2F10F7PLGF3 | |
| SCHEMBL6563630 | 0.80 | LMNA (0.37) | F2F10F7PLGF3 | |
| SCHEMBL7675036 | 0.77 | F10 (0.42) | F2F10F7PLGF3 | |
| SCHEMBL6565886 | 0.77 | F7 (0.35) | F2F10F7PLGF3 | |
| SCHEMBL6565349 | 0.76 | F2 (0.38) | F2F10F7PLGF3 | |
| SCHEMBL6563588 | 0.76 | F2 (0.41) | F2F10F7PLGF3 | |
| SCHEMBL6561958 | 0.75 | ACACB (0.49) | F2F10F7PLGF3 | |
| SCHEMBL7675063 | 0.74 | F2 (0.48) | F2F10PLGPLAUPLAT | |
| SCHEMBL7677130 | 0.73 | PRSS1 (0.41) | F2KLK1KLK5PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1140802-B1 | SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES | BOEHRINGER INGELHEIM PHARMA (DE) | 2004-03-17 | — | — | EP | disclosed |
| US-6479524-B1 | TO PROLONG THE THROMBIN TIME | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-11-12 | — | — | US | disclosed |